There is currently no strong evidence that additional immune therapy benefits patients with renal cell carcinoma who were ...

Immune checkpoint inhibitor-based combinations have become the preferred first-line therapy for patients with metastatic clear cell renal cell carcinoma, but more than a third of eligible patients do ...

During a live event, Guru P. Sonpavde, MD discussed improvements to survival with cabozantinib plus nivolumab in metastatic ...

Nivolumab plus ipilimumab showed a strong median overall survival (OS) advantage at 12 months and a trend toward overall ...

Doctors can combine immunotherapy with other treatments across various stages of renal cell carcinoma (RCC). Some types of immunotherapies involve the manipulation of immune checkpoint proteins.

Researchers from The University of Texas MD Anderson Cancer Center will present promising results from clinical trials in ...

immunotherapy has gained significant attention and, in many cases, has even replaced chemotherapy as the preferred treatment ...

Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad ...